Nanovaccine Institute

Revolutionizing how we prevent and treat diseases

Follow @Nanovax
  • Home
  • About
    • Video
    • Newsletter
    • Funding
    • Nanoscale
  • Research
    • Systems design of nanovaccines
    • Diseases and conditions
    • ENGAGE (Engineered Aging Enterprise)
  • Partners
    • Researchers
    • Institutions
  • Publications
  • Seminars
  • Videos
  • Links
  • Contacts
You are here: Home / Systems design of nanovaccines

Systems design of nanovaccines

 

We use a systems approach to vaccine development that is rooted in science and driven by first principles. This approach, which integrates nanotechnology, materials science, immunology, clinical science, and social science, will transform the design and manufacture of vaccines and therapeutics and enable rapid commercialization by encompassing bench-to-bedside considerations from conceptualization.

Our systems framework is based on five tightly integrated research thrusts:

Thrust 1: Novel antigen design and production

Thrust 2: Nanoscale adjuvants and delivery systems

Thrust 3: Vaccine efficacy and immunological mechanisms

Thrust 4: Scale-up, cGMP (current Good Manufacturing Practice) devices, and clinical testing

Thrust 5: Global deployability and economic analysis

These thrusts will be integrated to design nanovaccines against respiratory infections, tropical diseases, neurodegenerative disorders, cancer, diseases and conditions related to aging, and veterinary diseases. Our research will fill major gaps in basic research on vaccines and pre-clinical studies that lay the foundation for clinical trials.

Back to the top

Copyright © 2021 ยท Iowa State University of Science and Technology. All rights reserved. Credits